Vytorin Ads Face Congressional Scrutiny
Committees Raise Questions About Truthfulness Of Ads In Wake Of Negative Study Results
-
Play CBS Video
Video
Did Vytorin Withhold Info?
The makers of Vytorin are in hot water over when they knew the results of a report that revealed their drug was no better than the generic version and cost more. Susan Koeppen reports.
-
Video
More Questions About Vytorin
Questions remain about FDA approval of the cholesterol drug Vytorin, why studies showing its ineffectiveness were delayed, and why the company's president unloaded stock. Susan Koeppen reports.
-
Video
Congress Investigates Vytorin
Rep. Bart Stupak, chair of the house sub-committee investigating Vytorin, tells Julie Chen that they are troubled by evidence of data manipulation in clinical trials, and the withholding of results.
-
Photo
In 2005, the companies spent $155 million on Vytorin ads. (AP / file)
-
Quiz
Rx For Safe Medicines
Medicines: How Savvy Are You?
In letters dated Wednesday and addressed to Schering-Plough Corp. and Merck & Co., which jointly sell Vytorin, and the U.S. Food and Drug Administration, Reps. John Dingell and Bart Stupak, Michigan Democrats, raised questions about the ads for the medicine.
In the letter to the companies, the congressmen wrote that the House of Representatives' Committee on Energy and Commerce and its Subcommittee on Oversight and Investigations are probing the "withholding of clinical trial data that may significantly affect the medical management of hypercholesterolemia, as well as the use of misleading statement in direct-to-consumer advertisements for prescription medicines."
"There's certainly major misrepresentation, not only to the effectiveness of the drug, but manipulating of the scientific data to further promote a product that isn't doing what it is designed to do," Stupak told CBS' The Early Show.
Vytorin is in the news this week after the results of a long-awaited study, called Enhance, indicated the drug may be no better than a generic statin at slowing the progression of heart disease.
"The FDA certainly doesn't look good generally on monitoring advertisements. They've done a miserable job stopping ads that misrepresent drugs," Dr. Sidney Wolfe, director of Public Citizens Health Research Group, told The Early Show.
In the FDA letter, the lawmakers write that they are "concerned that the study's results may have been available to Schering-Plough and Merck officials, and yet the massive advertisement campaign for Vytorin was allowed to continue." They ask for agency records related to the Vytorin ads.
The congressmen also asked the companies for records related to the ads as well materials related to Enhance study leader John Kastelein, a cardiologist in the Netherlands. They also seek information about the press release this Monday that disclosed the Enhance results, almost two years after the last patient completed the study.
In 2005, the companies spent $155 million on Vytorin ads, a budget exceeded that year only by Sepracor Inc.'s Lunesta campaign and AstraZeneca PLC's Nexium ads, according to an article in the New England Journal of Medicine.
"There are several cholesterol-lowering drugs on the market that have been studied enough to show that they actually prevent heart attacks and strokes," Wolfe told The Early Show. "Vytorin, the combination of Zetia and another statin drug, is not one of these."
The companies have defended their handling of the Enhance study.
©MMVIII, CBS Broadcasting Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.



OH NO TELL ME IT ISN''T SO!
Come on, does this surprise anyone?
there is more profit in slowing down a disease long enough to milk your wallet before you die.
Oh no the trickle down theory at work again folks.
Bush appointed a bunch of drug lobbyists to run the FDA.
thank you
Florida
.
This is so simple even a moron could understand it: THERE IS NO JUSTIFIABLE REASON FOR MASS ADVERTISING PRESCRIPTION DRUGS ON TV OR ELSEWHERE!
Congress should BAN all advertising to the public (doctors excepted) for ALL prescription drugs.
.
Posted by connapa at 09:57 AM : Jan 17, 2008"
Even over-the-counter drugs are not exempt. Recently the drug companies had to pull children''s cold and flu remedies from the market because they pose a risk of death, while having little effect on the infection or symptoms.
-
by diportnoy
January 18, 2008 11:17 AM PST
- I was on VYTORIN 10/20 for 2 years + then on VYTORIN 10/10 for 8 months and lost a lot of leg mussel strength. Then for 2 months drug free, cholestral was elevated, so I was put on ZETIA for 1-1/2 months and I have the same mussel problems I have decided to go drug free since they are more harmful with thier side
-
Reply to this comment
-
See all 14 Commentseffects thn taking a chance with blockage.